(Q36643428)

English

Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer

scientific article published on September 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1 reference

based on heuristic

inferred from title

evasion of host immune response

1 reference

based on heuristic

inferred from title

colon adenocarcinoma

1 reference

based on heuristic

inferred from title

author name string

Song E

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Chen J

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Ouyang N

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Su F

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Wang M

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Heemann U

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

1 September 2001

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

85

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1047-1054

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Kupffer cells of cirrhotic rat livers sensitize colon cancer cells to Fas-mediated apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375090

30 September 2017

Malaria infection induces rapid elevation of the soluble Fas ligand level in serum and subsequent T lymphocytopenia: possible factors responsible for the differences in susceptibility of two species of Macaca monkeys to Plasmodium coatneyi infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375090

30 September 2017

Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375090

30 September 2017

Downregulation of Fas ligand by shedding

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375090

30 September 2017

Characterization of Fas (Apo-1, CD95)-Fas ligand interaction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375090

30 September 2017

Modulations of the effector function and cytokine production of human lymphocytes by secreted factors derived from colorectal-carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375090

30 September 2017

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375090

30 September 2017

CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375090

30 September 2017

Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375090

30 September 2017

The role of APO-1-mediated apoptosis in the immune system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375090

30 September 2017

The Fas death factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375090

30 September 2017

Fas ligand mediates activation-induced cell death in human T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375090

28 June 2018

Preoperative lymphocyte counts in peripheral blood in patients with colorectal neoplasms: a correlation with tumor type, Dukes' classification, site of primary tumor, and five-year survival rate in 1,000 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375090

28 June 2018

Elevated serum soluble Fas ligand in natural killer cell proliferative disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375090

20 September 2018

Clinical significance of serum soluble Fas ligand in patients with acute self-limited and fulminant hepatitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375090

20 September 2018

Levels of soluble Fas ligand in myocarditis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375090

20 September 2018

Fas ligand is constitutively secreted by prostate cancer cells in vitro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375090

20 September 2018

The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375090

20 September 2018

CD95(APO-1/Fas)-mediated apoptosis in normal and malignant liver, colon, and hematopoietic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375090

21 October 2018

Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11592778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11592778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Increased serum soluble Fas ligand in hyperthyroid Graves' disease]

1 reference

https://pubmed.ncbi.nlm.nih.gov/11592778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the effects of immunosuppressive factors from newly established colon carcinoma cell cultures on human lymphocyte proliferation and cytokine secretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/11592778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble Fas ligand expression in the ocular fluids of uveitis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11592778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fas ligand expression in esophageal carcinomas and their lymph node metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/11592778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased levels of soluble Fas receptor and Fas ligand in the cerebrospinal fluid of HIV-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11592778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver dysfunction due to apoptosis in a patient with systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/11592778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A role for CD95 ligand in preventing graft rejection

1 reference

https://pubmed.ncbi.nlm.nih.gov/11592778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

https://pubmed.ncbi.nlm.nih.gov/11592778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fas ligand in human serum

1 reference

https://pubmed.ncbi.nlm.nih.gov/11592778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligand

1 reference

https://pubmed.ncbi.nlm.nih.gov/11592778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

https://pubmed.ncbi.nlm.nih.gov/11592778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus

1 reference

https://pubmed.ncbi.nlm.nih.gov/11592778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Requirement of cell-cell contact in the induction of Jurkat T cell apoptosis: the membrane-anchored but not soluble form of FasL can trigger anti-CD3-induced apoptosis in Jurkat T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/11592778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oligoclonal T cells in human cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11592778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions

1 reference

https://pubmed.ncbi.nlm.nih.gov/11592778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levels of soluble FasL and FasL gene expression during the development of graft-versus-host disease in DLT-treated patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11592778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble fas ligand in natural killer cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11592778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6692042

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36643428&oldid=1642924472"